The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2020, at a CAGR 7.2% from 2021 to 2026. The growth of this market is driven by increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicines.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
The cell lysis market is highly consolidated and is dominated by various players. The major players operating in this market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), Agilent Technologies Inc. (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), NZYTech Lda (Portugal), Labfreez Instruments Group Co., Limited (China), G-Biosciences (US), Covaris (US), Claremont BioSolutions LLC (US), Microfluidics International Corporation (US), Parr Instrument Company (US), BioVision Inc.(US), and Norgen Biotek (Canada).
Thermo Fisher Scientific (US)
Thermo Fisher Scientifc (US) held the leading position in the cell lysis market in 2020. Thermo Fisher offers an exhaustive product portfolio consisting of various cell lysis products, such as reagents, kits, and media. The company believes in both organic and inorganic growth for enhancing its market position such collaboration, acquisition and expansion. For instance, in 2020, Thermo Fisher Scientific entered collaboration with Northeastern University To advance analytical capabilities and accelerate innovation across the biopharmaceutical industry in personalized medicine, monoclonal antibodies, and gene and cell therapies. Furthermore, the company is innovation-centric and invests heavily in R&D to maintain its market share..
Merck (Germany)
Merck (Germany) accounted for the second-largest share of the global cell lysis market in 2020. The company provides its radiation dowing to its robust portfolio of cell lysis products and efforts to develop innovative products by investing in R&D. To sustain its leading position in the cell lysis market, the company pursues organic and inorganic strategies such as expansion. For instance, in 2020, the company expanded Life Science production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, US
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260138321
North America accounted for the largest share of the cell lysis inudstry.
Based on the region, the cell lysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the global market. The large share of North America can be attributed to factors such as growing stem cell and cancer research activities and the expanding biotechnology & pharmaceutical industries
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
